NO20044321L - Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase - Google Patents
Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfataseInfo
- Publication number
- NO20044321L NO20044321L NO20044321A NO20044321A NO20044321L NO 20044321 L NO20044321 L NO 20044321L NO 20044321 A NO20044321 A NO 20044321A NO 20044321 A NO20044321 A NO 20044321A NO 20044321 L NO20044321 L NO 20044321L
- Authority
- NO
- Norway
- Prior art keywords
- piperidinylamine
- piperazinyl
- acid amides
- sulfamic acid
- inhibitors
- Prior art date
Links
- 108010087999 Steryl-Sulfatase Proteins 0.000 title abstract 2
- 102100038021 Steryl-sulfatase Human genes 0.000 title abstract 2
- 125000004193 piperazinyl group Chemical group 0.000 title abstract 2
- JUTQLSRBKSVCLI-UHFFFAOYSA-N piperidin-1-amine;sulfamide Chemical class NS(N)(=O)=O.NN1CCCCC1 JUTQLSRBKSVCLI-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0207500A GB0207500D0 (en) | 2002-03-28 | 2002-03-28 | Organic compounds |
GB0225679A GB0225679D0 (en) | 2002-11-04 | 2002-11-04 | Organic compounds |
PCT/EP2003/003214 WO2003082842A1 (en) | 2002-03-28 | 2003-03-27 | Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044321L true NO20044321L (no) | 2004-10-12 |
Family
ID=28676499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044321A NO20044321L (no) | 2002-03-28 | 2004-10-12 | Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase |
Country Status (20)
Country | Link |
---|---|
US (2) | US7439362B2 (ja) |
EP (1) | EP1492782A1 (ja) |
JP (1) | JP4580652B2 (ja) |
KR (1) | KR20040094877A (ja) |
CN (1) | CN1293065C (ja) |
AR (1) | AR039156A1 (ja) |
AU (1) | AU2003226732B2 (ja) |
BR (1) | BR0308795A (ja) |
CA (1) | CA2480686A1 (ja) |
CO (1) | CO5640113A2 (ja) |
IL (1) | IL164267A0 (ja) |
MX (1) | MXPA04009453A (ja) |
MY (1) | MY136880A (ja) |
NO (1) | NO20044321L (ja) |
NZ (1) | NZ535617A (ja) |
PE (1) | PE20040167A1 (ja) |
PL (1) | PL372602A1 (ja) |
RU (1) | RU2329258C2 (ja) |
TW (1) | TW200306806A (ja) |
WO (1) | WO2003082842A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0505541D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
GB0505539D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
GB0511190D0 (en) * | 2005-06-01 | 2005-07-06 | Sterix Ltd | Use |
EP2207544A2 (en) | 2007-09-17 | 2010-07-21 | PregLem S.A. | Treatment of oestrogen dependant conditions in pre-menopausal women |
CN109152844B (zh) * | 2016-02-08 | 2022-11-22 | 西纳福克斯股份有限公司 | 用于治疗的含有磺酰胺接头的生物缀合物 |
EP3413915A1 (en) | 2016-02-08 | 2018-12-19 | Synaffix B.V. | Antibody-conjugates with improved therapeutic index for targeting her2 tumours and method for improving therapeutic index of antibody-conjugates |
EP3413922A1 (en) | 2016-02-08 | 2018-12-19 | SynAffix B.V. | Improved sulfamide linkers for use in bioconjugates |
JP2020502064A (ja) * | 2016-11-29 | 2020-01-23 | エピザイム,インコーポレイティド | スルホン酸基を含むkat阻害剤としての化合物 |
EP3983388A1 (en) * | 2019-06-12 | 2022-04-20 | Nodthera Limited | Sulfonamide derivatives and uses thereof |
CN110590896B (zh) * | 2019-11-04 | 2022-08-30 | 上海高准医药有限公司 | 雌酚酮硫酸酯哌嗪的制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US183459A (en) * | 1876-10-17 | Improvement in hinges | ||
US89089A (en) * | 1869-04-20 | Improved car-coupling | ||
US478328A (en) * | 1892-07-05 | Glass-heating oven | ||
US51547A (en) * | 1865-12-19 | Improvement in guide and tuck-marker for sewing-machines | ||
US71516A (en) * | 1867-11-26 | William b | ||
US876846A (en) * | 1907-05-28 | 1908-01-14 | Stephen W Smith | Road-machine. |
US1122242A (en) * | 1912-05-13 | 1914-12-29 | Sanitary Can Company | Can-body-feeding device. |
US2103610A (en) * | 1935-04-30 | 1937-12-28 | Sofal Ltd | Alloy steels |
DE876846C (de) * | 1943-06-01 | 1953-05-18 | Bayer Ag | Verfahren zur Herstellung von Abkoemmlingen des Sulfondiamids |
US3004487A (en) * | 1959-12-07 | 1961-10-17 | Bank Of America Nat Trust & Savings Ass | Imprinters |
GB1593609A (en) * | 1978-01-31 | 1981-07-22 | Christiaens Sa A | Pyridine sulfonamides |
FR2510106A1 (fr) | 1981-07-27 | 1983-01-28 | Rhone Poulenc Agrochimie | Composes herbicides derives d'acides phenoxybenzoiques, et leurs procedes de preparation et d'utilisation |
DK101683A (da) * | 1982-03-12 | 1983-09-13 | Duphar Int Res | Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf |
US5238923A (en) * | 1989-05-26 | 1993-08-24 | Warner-Lambert Company | Amino-substituted heterocycles as renin inhibitors |
US5256632A (en) * | 1990-05-30 | 1993-10-26 | Bayer Aktiengesellschaft | Herbicidal sulphonylated carboxamides |
IL99537A (en) | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
FR2716882B1 (fr) * | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
FR2716883B1 (fr) * | 1994-03-04 | 1996-04-26 | Roussel Uclaf | Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant. |
US5464788A (en) | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
WO1996002530A1 (en) | 1994-07-20 | 1996-02-01 | Merck & Co., Inc. | Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone |
KR970706242A (ko) | 1994-10-04 | 1997-11-03 | 후지야마 아키라 | 우레아 유도체 및 ACAT-억제제로서 그의 용도(Urea derivatives and their use as ACAT-inhibitors) |
WO1997020820A1 (en) | 1995-12-01 | 1997-06-12 | Novartis Ag | Heteroaryl compounds |
DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19621482A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0977772A1 (en) | 1997-04-14 | 2000-02-09 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
EP1122242B1 (en) | 1998-09-22 | 2008-01-16 | Astellas Pharma Inc. | Cyanophenyl derivatives |
JP2002542155A (ja) | 1999-03-03 | 2002-12-10 | メルク エンド カムパニー インコーポレーテッド | プレニル蛋白トランスフェラーゼの阻害剤 |
AU5283600A (en) | 1999-05-24 | 2000-12-12 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
JP4320089B2 (ja) * | 1999-07-06 | 2009-08-26 | あすか製薬株式会社 | フェニルスルファメート誘導体 |
US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
IL148464A0 (en) | 2000-05-04 | 2002-09-12 | Basf Ag | Uracil substituted phenyl sulfamoyl carboxamides |
JP2005505506A (ja) * | 2001-06-12 | 2005-02-24 | イーラン ファーマスーティカルズ、インコーポレイテッド | アルツハイマー病の治療に有用な大環状分子 |
BR0210733A (pt) | 2001-07-02 | 2004-07-20 | Astrazeneca Ab | Derivados de piperidina de utilidade úteis como moduladores da atividade do receptor de quimocina |
-
2003
- 2003-03-26 PE PE2003000308A patent/PE20040167A1/es not_active Application Discontinuation
- 2003-03-26 AR ARP030101062A patent/AR039156A1/es unknown
- 2003-03-27 MX MXPA04009453A patent/MXPA04009453A/es active IP Right Grant
- 2003-03-27 KR KR10-2004-7015312A patent/KR20040094877A/ko not_active Application Discontinuation
- 2003-03-27 TW TW092106942A patent/TW200306806A/zh unknown
- 2003-03-27 US US10/509,259 patent/US7439362B2/en not_active Expired - Fee Related
- 2003-03-27 EP EP03745281A patent/EP1492782A1/en not_active Withdrawn
- 2003-03-27 AU AU2003226732A patent/AU2003226732B2/en not_active Ceased
- 2003-03-27 BR BR0308795-6A patent/BR0308795A/pt not_active IP Right Cessation
- 2003-03-27 CA CA002480686A patent/CA2480686A1/en not_active Abandoned
- 2003-03-27 NZ NZ535617A patent/NZ535617A/en unknown
- 2003-03-27 JP JP2003580309A patent/JP4580652B2/ja not_active Expired - Fee Related
- 2003-03-27 WO PCT/EP2003/003214 patent/WO2003082842A1/en active Application Filing
- 2003-03-27 CN CNB038083361A patent/CN1293065C/zh not_active Expired - Fee Related
- 2003-03-27 PL PL03372602A patent/PL372602A1/xx unknown
- 2003-03-27 IL IL16426703A patent/IL164267A0/xx unknown
- 2003-03-27 RU RU2004131822/04A patent/RU2329258C2/ru not_active IP Right Cessation
- 2003-03-28 MY MYPI20031151A patent/MY136880A/en unknown
-
2004
- 2004-09-28 CO CO04096497A patent/CO5640113A2/es unknown
- 2004-10-12 NO NO20044321A patent/NO20044321L/no not_active Application Discontinuation
-
2008
- 2008-09-16 US US12/211,525 patent/US20090042899A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CO5640113A2 (es) | 2006-05-31 |
US20090042899A1 (en) | 2009-02-12 |
US7439362B2 (en) | 2008-10-21 |
US20060052393A1 (en) | 2006-03-09 |
MXPA04009453A (es) | 2005-01-25 |
CN1293065C (zh) | 2007-01-03 |
AU2003226732B2 (en) | 2006-12-21 |
IL164267A0 (en) | 2005-12-18 |
EP1492782A1 (en) | 2005-01-05 |
TW200306806A (en) | 2003-12-01 |
RU2329258C2 (ru) | 2008-07-20 |
PL372602A1 (en) | 2005-07-25 |
JP4580652B2 (ja) | 2010-11-17 |
RU2004131822A (ru) | 2005-07-10 |
AR039156A1 (es) | 2005-02-09 |
BR0308795A (pt) | 2005-01-18 |
WO2003082842A1 (en) | 2003-10-09 |
CA2480686A1 (en) | 2003-10-09 |
AU2003226732A1 (en) | 2003-10-13 |
MY136880A (en) | 2008-11-28 |
PE20040167A1 (es) | 2004-05-26 |
CN1646509A (zh) | 2005-07-27 |
NZ535617A (en) | 2006-04-28 |
KR20040094877A (ko) | 2004-11-10 |
JP2005526812A (ja) | 2005-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
DK1347955T3 (da) | Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere | |
DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
BRPI0513864A (pt) | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades | |
NO20060416L (no) | Ny anvendelse I | |
NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
NO20076206L (no) | Kombinasjon av PDE4 inhibitor romflumilast og et tetrahydrobioterin-derivativ | |
DK1261600T3 (da) | Heteroaromatiske carboxamidderivater og deres anvendelse som inhibitorer af enzymet IKK-2 | |
IS7543A (is) | Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær | |
NO20055496D0 (no) | Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer | |
ATE411022T1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
DE50312034D1 (de) | Liposomale glucocorticoide | |
WO2005044199A3 (en) | Combination of proton pump inhibitor and sleep aid | |
NO20076616L (no) | 17beta-HSD1- og STS-inhibitorer | |
IS7840A (is) | 3-(3,5-díoxó-4,5-díhýdró-3H-(1,2,4)tríasín-2-ýl)-bensamíð afleiður sem P2X7-hindrar til notkunar í meðferð á bólguvaldandi sjúkdómum | |
NO20051107L (no) | Substituerte tienylhydroksaminsyrer og deres anvendelse til behandling av sykdommer forbundet med enzymatisk histondeacetylueaktivitet | |
NO20062335L (no) | Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer | |
HN2001000019A (es) | Derivados de nicotinamida benzocondensada heterociclico utiles como inhibidores selectivos de las isozimas pde4. | |
DK1546127T3 (da) | Nye pyrimidinamidderivater og anvendelse deraf | |
ATE542804T1 (de) | 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen | |
NO20044321L (no) | Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase | |
NO20043792L (no) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
NO20080035L (no) | Benzooksazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
NO20034237L (no) | Ny fremgangsmate for den industrielle syntese av metyldiesteren av 5-amino-3-karboksymetyl-4-cyano-2-tiofenkarboksylsyre, og anvendelse i syntesen av bivalente salter av ranelinsyre og deres hydrater | |
SE0300445D0 (sv) | New combination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |